Furthermore, patients with Rab27A (+) or Rab27B (+) exhibit significantly decreased OS compared with those showing Rab27A (−) or Rab27B (−) in hepatocellular carcinoma [12]. This evidence concerns the gene RAB27A and hepatocellular carcinoma.